Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial. | Zendy

G. L. Lenzi | Zendy; Francesco Grigoletto | Zendy; Michael Gent | Zendy; R S Roberts | Zendy; Michael Walker | Zendy; J. Donald Easton | Zendy; A Carolei | Zendy; Frank C. Dorsey | Zendy; Walter A. Rocca | Zendy; R. Bruno | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.

Author(s) -

G. L. Lenzi,

Francesco Grigoletto,

Michael Gent,

R S Roberts,

Michael Walker,

J. Donald Easton,

A Carolei,

Frank C. Dorsey,

Walter A. Rocca,

R. Bruno

Publication year - 1994

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.25.8.1552

Subject(s) - medicine , placebo , stroke (engine) , adverse effect , clinical trial , anesthesia , randomized controlled trial , post hoc analysis , surgery , mechanical engineering , alternative medicine , pathology , engineering

The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect of monosialoganglioside GM-1 in improving recovery in patients who experienced an ischemic supratentorial stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research